If you're taking a GLP-1 medication like semaglutide or tirzepatide, your appetite may be lower than it's been in years
Based on the different molecular structures and PK characteristics of the GLP-1 RAs and the presence of GLP-1 receptors on the sinoatrial node, differential effects on HR may be expected
For advanced type 2 diabetes with significant beta cell failure, or for type 1 diabetes, Tresiba (or another insulin) is essential and often superior to or required in addition to GLP-1 therapy
Patients often feel fuller sooner, have fewer cravings, and experience steadier energy levels throughout the day
Peptide therapy intervenes in hormonal signaling to lower appetite and improve glycemic control, making dietary changes more achievable
later, 0.51 pound weekly is sustainable and normal as your body nears a new set point